Non-Insulin Surrogates for Tracking Systemic Insulin Resistance

23 concepts22 papers1 proposal

Insulin resistance is the silent engine driving a vast spectrum of chronic conditions, from type 2 diabetes to heart failure and chronic kidney disease. Yet, clinically tracking this critical variable is notoriously difficult. The gold standard for measuring insulin sensitivity—the hyperinsulinemic-euglycemic clamp—requires continuous intravenous infusions and frequent blood sampling over several hours, making it entirely impractical for routine clinical care or large-scale epidemiological studies.

Even simpler alternatives like the Homeostasis Model Assessment of Insulin Resistance (HOMA-IR), used by researchers such as Bin Zhang et al. in Altered Regional Gray Matter Volume in Obese Men: A Structural MRI Study and Kadir Öztürk et al. in Pentraxin 3 Is a Predictor for Fibrosis and Arterial Stiffness in Patients with Nonalcoholic Fatty Liver Disease, rely on direct fasting insulin assays. These assays are expensive, poorly standardized across laboratories, and rarely included in standard blood panels.

To circumvent this bottleneck, a powerful paradigm has emerged: metabolic surrogate indexing. Instead of measuring insulin directly, this approach uses mathematical formulas to extract an insulin-resistance signal from routine, low-cost clinical measurements. Rather than relying on dynamic challenge tests that calculate indices from multiple post-load blood draws—such as those explored by Lei Zhuang et al. in Serum Amylase Levels in Relation to Islet β Cell Function in Patients with Early Type 2 Diabetes or the C-peptide-derived indices utilized by Xiaohua Wang et al. in Fasting serum total bile acid levels are associated with insulin sensitivity, islet β-cell function and glucagon levels in response to glucose challenge in patients with type 2 diabetes—metabolic surrogate indexing leverages steady-state, readily available physiological data.

Why It Works: The Multi-Organ Footprint

How can we measure insulin resistance without measuring insulin? The answer lies in the systemic nature of metabolic dysfunction. Insulin resistance is not merely a localized defect in muscle glucose uptake; it is a coordinated breakdown of glucose and lipid regulation across multiple organs, particularly the liver and adipose tissue.

In a healthy state, insulin suppresses both hepatic glucose production and the breakdown of fats (lipolysis) in adipose tissue. When tissues become resistant to insulin, two things happen simultaneously: the liver continues to release glucose into the bloodstream, and it accelerates the synthesis of triglycerides from unchecked free fatty acids. Consequently, systemic insulin resistance leaves a distinct, dual footprint in fasting blood work: elevated glucose and elevated triglycerides.

By combining these two downstream readouts, mathematical proxies can capture the underlying state of insulin resistance. The most prominent of these is the Triglyceride-Glucose (TyG) index, calculated as:

$$\text{TyG} = \ln \left( \frac{\text{Fasting Triglycerides } (\text{mg/dL}) \times \text{Fasting Glucose } (\text{mg/dL})}{2} \right)$$

The natural logarithm is crucial here: it linearizes the relationship between worsening metabolic health and biochemical markers, stabilizing variance and making the index a highly reliable continuous metric. As noted by You Zhou et al. in Association between the triglyceride–glucose index and the risk of mortality among patients with chronic heart failure: results from a retrospective cohort study in China, this simple formula bypasses the need for specialized insulin assays entirely, offering a high-fidelity mirror of multi-organ metabolic breakdown.

Expanding the Proxy: METS-IR and eGDR

While the TyG index captures the core glucose-lipid axis, other surrogates expand this mathematical representation to incorporate physical indicators of metabolic syndrome, such as adiposity and vascular stress.

The Metabolic Score for Insulin Resistance (METS-IR) builds upon the TyG framework by integrating body mass index (BMI) and normalizing the score by high-density lipoprotein cholesterol (HDL-C) levels. Because low HDL-C and high BMI are direct structural and biochemical consequences of visceral fat accumulation, METS-IR provides a more comprehensive picture of adiposity-driven insulin resistance. You Zhou et al. demonstrated in Metabolic score for insulin resistance as a predictor of mortality in heart failure with preserved ejection fraction: results from a multicenter cohort study that this multi-faceted score effectively captures systemic risk by leveraging readily available physiological metrics.

Similarly, the Estimated Glucose Disposal Rate (eGDR) shifts the focus toward long-term glycemic control and vascular health. It integrates hemoglobin A1c (HbA1c), hypertension status, and anthropometric measurements into a single weighted formula. As explained by Xiangkun Wang et al. in Association between estimated glucose disposal rate and heart failure in patients with diabetes or prediabetes: a cross-sectional study, eGDR serves as a stable proxy specifically tuned to estimate how effectively peripheral tissues clear glucose under metabolic duress.

Predicting Macrovascular and Microvascular Complications

Because these surrogate indices reflect chronic, systemic metabolic stress, they have extraordinary prognostic value across diverse organ systems. They act as early warning systems for both macrovascular (large blood vessel) and microvascular (small blood vessel) damage.

Cardiovascular Disease

The vascular endothelium is highly sensitive to the metabolic disturbances captured by the TyG index. Shiyi Tao et al. in Association between the triglyceride-glucose index and 1-year major adverse cardiovascular events in patients with coronary heart disease and hypertension and Prognostic value of triglyceride-glucose index in patients with chronic coronary syndrome undergoing percutaneous coronary intervention established that elevated TyG scores strongly predict major adverse cardiovascular events (MACE), such as myocardial infarction and stroke.

The risk is particularly pronounced when tracking the index over time; Xueyao Yang et al. in The association between triglyceride–glucose index and the recurrence of myocardial infarction in young patients with previous coronary heart disease found that longitudinal monitoring of TyG levels is essential for predicting recurrent heart attacks in young patients.

Furthermore, the biological pathway connecting insulin resistance to cardiac ischemia often requires an intermediate organ. Using mediation analysis, Tian Yu et al. discovered in The metabolic score for insulin resistance index is associated with myocardial ischemia, with non-alcoholic fatty liver disease serving as an important bridge that non-alcoholic fatty liver disease (NAFLD) acts as a complete biological bridge, translating systemic insulin resistance (measured via METS-IR) into restricted blood flow to the heart.

End-Organ and Microvascular Damage

Beyond the heart, these indices track microvascular decline in the kidneys, brain, and hepatobiliary system:

Nonlinear Thresholds and the Metabolic Paradox

A key strength of surrogate indexing is its ability to uncover non-linear clinical thresholds where metabolic risk abruptly shifts. For instance, Qiang Xu et al. in Association between metabolic score for insulin resistance and regression to normoglycemia from prediabetes in Chinese adults: A retrospective cohort study identified a non-linear threshold in METS-IR scores that dictates whether an individual with prediabetes can successfully reverse their condition back to normal blood sugar levels. Similarly, Santiago Navas‐Carretero et al. in Appraisal of Triglyceride-Related Markers as Early Predictors of Metabolic Outcomes in the PREVIEW Lifestyle Intervention: A Controlled Post-hoc Trial showed that baseline TyG scores can predict the magnitude of an individual's response to long-term lifestyle interventions.

However, applying these indices across diverse age groups reveals fascinating physiological nuances. In extreme old age, the relationship between metabolic proxies and mortality can invert entirely.

[ Young / Middle-Aged Adults ] ──> High TyG/METS-IR ──> Vascular Stress & High Mortality Risk
[ Centenarians (Paradox) ]     ──> Low TyG/METS-IR  ──> Depleted Energy Reserves & High Mortality Risk

Shiju Yan et al. uncovered this "metabolic paradox" in Associations of the triglyceride–glucose index and triglyceride–glucose/body mass index with all-cause mortality in Chinese centenarians, finding that lower TyG and TyG-BMI scores were associated with a higher risk of death among centenarians. This suggests that while high lipid and glucose concentrations signify dangerous insulin resistance in young and middle-aged adults—as seen in the hypertension cohort studied by Lishui Chen et al. in Prognostic value of the triglyceride-glucose index for adverse cardiovascular outcomes in young adult hypertension—they may represent vital energy and metabolic reserves necessary for survival in the oldest-old.

Key Foundational Work

Serum Amylase Levels in Relation to Islet β Cell Function in Patients with Early Type 2 Diabetes (2016) — contributed 1 concept elements to this direction.
Altered Regional Gray Matter Volume in Obese Men: A Structural MRI Study (2017) — contributed 1 concept elements to this direction.
Pentraxin 3 Is a Predictor for Fibrosis and Arterial Stiffness in Patients with Nonalcoholic Fatty Liver Disease (2016) — contributed 1 concept elements to this direction.
History & citationVersion 2 · 2026-10-04

Current · Permanent link

  1. Version 2 (latest) · 2026-10-04 · 22 papers
  2. Version 1 · 2026-10-04 · 37 papers
Cite this direction

Latest version (a living page):

@misc{lacuna_metabolic_surrogate_indexing_daca8d5c,
  title = {metabolic surrogate indexing},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/metabolic-surrogate-indexing/rdr_daca8d5cfbf34a56937e28f741265a7f},
  note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-20},
}

This exact version (version 2, frozen text):

@misc{lacuna_metabolic_surrogate_indexing_daca8d5c_v2,
  title = {metabolic surrogate indexing},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/metabolic-surrogate-indexing/rdr_daca8d5cfbf34a56937e28f741265a7f/v/2},
  note = {Version 2, frozen 2026-10-04. Accessed 2026-11-20},
}
About

These directions overlap with this one through shared papers.

See something wrong? Report a mistake